Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation

1979 ◽  
Vol 15 (2) ◽  
pp. 97-103 ◽  
Author(s):  
C. P. Quarterman ◽  
M. J. Kendall ◽  
P. G. Welling
Keyword(s):  
Sustained Release ◽  
Plasma Levels ◽  
Chronotropic Effect ◽  
Release Formulation ◽  
Sustained Release Formulation ◽  
Negative Chronotropic Effect

▾ Piretanide for hypertension

1985 ◽  
Vol 23 (11) ◽  
pp. 43-44
Keyword(s):  
Glucose Tolerance ◽  
Sustained Release ◽  
Loop Diuretic ◽  
Plasma Potassium ◽  
Release Formulation ◽  
Sustained Release Formulation ◽  
Treatment Of Hypertension

Piretanide is a loop diuretic recently marketed in a sustained-release formulation (Arelix - Hoechst) solely for the treatment of hypertension (rather than as a general diuretic). The manufacturer claims that piretanide has several advantages over the thiazides, including little or no effect on plasma potassium and magnesium, and no impairment of glucose tolerance.

Sustained release formulation of Ondansetron HCl using osmotic drug delivery approach

2020 ◽  
Vol 46 (3) ◽  
pp. 343-355
Author(s):  
Ramakant Gundu ◽  
Sanjay Pekamwar ◽  
Santosh Shelke ◽  
Santosh Shep ◽  
Deepak Kulkarni
Keyword(s):  
Drug Delivery ◽  
Sustained Release ◽  
Release Formulation ◽  
Sustained Release Formulation ◽  
Delivery Approach
Sign in / Sign up

Export Citation Format

Share Document